Extended Data Fig. 4: Progression-free survival by treatment arm in the GA plus placebo, GA plus IV paricalcitol and GA plus PO paricalcitol arms. | Nature Cancer

Extended Data Fig. 4: Progression-free survival by treatment arm in the GA plus placebo, GA plus IV paricalcitol and GA plus PO paricalcitol arms.

From: Gemcitabine and nab-paclitaxel with or without the VDR agonist paricalcitol for metastatic pancreatic cancer: a randomized, multiarm, run-in phase trial

Extended Data Fig. 4: Progression-free survival by treatment arm in the GA plus placebo, GA plus IV paricalcitol and GA plus PO paricalcitol arms.The alternative text for this image may have been generated using AI.

Barplots indicating progression-free survival, colored by treatment arm and including reasons for stopping treatment. Abbreviations: GA: gemcitabine and albumin-bound (nab-) paclitaxel; PO: per os; IV: intravenous.

Source data

Back to article page